Brain Cancer

Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling

Post author:
Post published:March 31, 2025
Post category:

Research Objective This DISC2 tests a strategy to target survival and self-renewal in glioma stem cells (GSC), and will identify a therapeutic candidate for safety, dosing and efficacy testing. Impact…

Development of a Trifunctional Self-Renewing Memory CAR T Cell Therapy to Overcome the Heterogeneity and Suppressive Microenvironment of Glioblastoma

Post author:
Post published:March 31, 2025
Post category:

Research Objective This personalized chimeric antigen receptor (CAR) T cell therapy will attack a wider range of cancer cells, and block cancer's defense mechanisms to empower the immune system to…

Development of novel small molecules against cancer stem cells in solid cancers

Post author:
Post published:March 31, 2025
Post category:

Research Objective To study and optimize lead compounds with multi-kinase activity against existing glioma stem cells and radiation-induced phenotype conversion of non-stem glioma cells into induced glioma stem cells. Impact…

Stem cell-derived extracellular vesicles to reverse radiation-induced brain injury

Post author:
Post published:March 31, 2025
Post category:

Research Objective These preclinical studies will discover the efficacy of stem cell-derived, nanoscale, extracellular vesicles (candidate) to treat adverse effects of cancer therapy on brain function and cognition. Impact Stem…

Non-viral reprogramming of the endogenous TCRα locus to direct stem memory T cells against shared neoantigens in malignant gliomas

Post author:
Post published:March 31, 2025
Post category:

Research Objective We will develop a non-viral gene editing technology to replace the endogenous TCRα locus of stem memory T cells with transgene TCRs that are specific to brain cancer…

A Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors

Post author:
Post published:March 31, 2025
Post category:

Development of an AAV gene therapy immunotherapy for the treatment of glioblastoma

Post author:
Post published:March 31, 2025
Post category:

Translational Candidate SRN-101, an experimental AAV gene therapy for treating glioblastoma Area of Impact Cancer - solid tumors Mechanism of Action Following delivery with an AAV, engineered cytokines are expressed…

Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma

Post author:
Post published:March 31, 2025
Post category:

Translational Candidate Human T cells transduced with a lentiviral vector encoding anti-EGFRvIII synNotch-primed anti-EphA2/IL-13Rα2 chimeric antigen receptor. Area of Impact Glioblastoma is the most common malignant brain tumor, affecting approximately…

Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma

Post author:
Post published:March 31, 2025
Post category:

Translational Candidate Human T cells transduced with a lentiviral vector encoding anti-EGFRvIII synNotch-primed anti-EphA2/IL-13Rα2 chimeric antigen receptor. Area of Impact Glioblastoma is the most common malignant brain tumor, affecting approximately…

2nd Generation Vaccine for the Treatment of Glioblastoma

Post author:
Post published:March 31, 2025
Post category:

Translational Candidate It is the peptide LEEKKYNYVVVTDHC conjugated to KLH and used as an anti-cancer vaccine. Area of Impact This is a better optimized, more robust vaccine that aspires to…

Subscribe to Receive CIRM News